Moderna Inc (MRNA)
121.85
+0.80
(+0.66%)
USD |
NASDAQ |
May 08, 16:00
121.82
-0.02
(-0.02%)
After-Hours: 19:08
Moderna Gain/Loss on Sale Business (Quarterly)
Gain/Loss on Sale Business (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gain/Loss on Sale Business (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
Date | Value |
---|---|
December 31, 2022 | -- |
September 30, 2022 | -- |
June 30, 2022 | -- |
Gain (Loss) on Sale of Business Definition
Gain (Loss) on Sale of Business is the financial result that arises when the company sells a portion of its business or a subsidiary. If company sells the business segment for greater than its book value a gain is realized, if it is sold for less, a loss is realized. Gain (Loss) on Sale of Business is considered an operating activity and part of a company's core business. Gain (Loss) on Sale of Business is taken from a company's cash flow statement.
Gain/Loss on Sale Business (Quarterly) Range, Past 5 Years
Gain/Loss on Sale Business (Quarterly) Benchmarks
Merck & Co Inc | -- |
Pfizer Inc | -- |
Eli Lilly and Co | -- |
Johnson & Johnson | -- |
Novavax Inc | -- |